OKYO Pharma Ltd — Share Issue/Capital Change 2018

Nov 1, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9455F

OKYO Pharma Limited

01 November 2018

1 November 2018

OKYO Pharma Limited

(Incorporated and registered in Guernsey with registered number 65220) 

Expected Admission Date for Consideration Shares

OKYO Pharma Limited (LSE:OKYO) (the "Company") today announces that in connection with its announcement on 24 October 2018 (the "24 October Announcement"), regarding its agreement to allot 512,866 ordinary shares of no par value in the capital of the Company (the "Consideration Shares") to Dr. Alan Kopin and Dr. Benjamin Harwood in lieu of a cash payment pursuant to the terms of the Amended Collaboration Agreement (as defined in the 24 October Announcement), that such Consideration Shares are expected to be admitted to listing on the standard segment of the Official List maintained by the Financial Conduct Authority under Chapter 14 of the Listing Rules and to trading on the main market for listed securities of London Stock Exchange plc on 5 November 2018.

End

Enquiries:

OKYO Pharma Limited	Willy Simon	+44 (0)20 7382 8300
Stockdale Securities Limited (Broker)	Andy Crossley Antonio Bossi David Coaten	+44 (0)20 7601 6100

For further information, please visit the Company's website at www.okyopharma.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCDMMFGNMVGRZM